ARTICLE | Company News
viDA Therapeutics, Centre for Drug Research and Development deal
November 16, 2015 8:00 AM UTC
The center and viDA partnered to develop VTI-1002 to treat discoid lupus erythematosus (DLE). The partners will develop a clinical-grade formulation of the preclinical topical small molecule granzym...